This message contains images. If you don't see images, click here to view.
Advertise in this news brief.

  Text Version   RSS   Subscribe   Unsubscribe   Archive   Media Kit         July 8, 2016



Inventorship and Ownership of Patents in the Workplace Share on FacebookTwitterShare on LinkedinE-mail article
Y ou just started a new job at PharmaCo in the medicinal chemistry division. For your first project, you are synthesizing a brand new class of compounds directed to a particular target. You and the project leader have put together a novel scaffold and made dozens of compounds using that scaffold. At a team meeting, the results of the program are given, and a patent attorney from the legal department is also present. The patent application is prepared and filed with all necessary paperwork, and shortly thereafter, you are presented with paperwork and told to affix your signature. You sign the documents as do all of the other inventors. What did you just do?

Read more in the July 2016 AAPS Newsmagazine (member login required).


Job Title Company Location
Associate Scientist / Scientist, PTPK Genentech South San Francisco, CA
Biopharmaceutical Product Scientist GlaxoSmithKline King of Prussia, PA
Scientist, Bioanalytical Development Seattle Genetics Bothell, WA
Director of Quality Eisai Inc. Baltimore, MD

For a complete list of job postings, click here.

Have a job to post? Click here.


The Secret to Resume Success Share on FacebookTwitterShare on LinkedinE-mail article
The Huffington Post
Did you ever apply for a job that you were certain you were perfect for...and then hear back nothing? The lack of response may have nothing to do with your experience, and everything to do with how you’re presenting it on your resume. These days, recruiters receive thousands of resumes for desirable positions. Because of these enormous numbers, 98% of job-seekers don’t make it past the original resume screening, according to Robert Meier, President of Job Market Experts.  READ MORE

Clinical Trials Driving Excellence in Healthcare Industry Share on FacebookTwitterShare on LinkedinE-mail article
The Daily Star
Once a new drug is developed, it is essential to conduct a clinical trial that allows the drug to be tested regarding safety and efficacy in human volunteers. Generally, the company files an “investigational new drug” application with the Food and Drug Administration to allow the investigational drug to be tested in human volunteers in clinical trials.  READ MORE

Job Search 50: Land Your Next Job With Targeted Networking Share on FacebookTwitterShare on LinkedinE-mail article
The Huffington Post
Has your job search stalled? Are you feeling isolated and discouraged? Do you believe your age alone has led to major setbacks and missed opportunities? If you answered, “yes” to any of these questions, you just might find yourself pleasantly surprised. How? What could you possibly do to overcome the multiple negative perceptions of age? The answer isn’t all that surprising: refocus your job search!  READ MORE

The State of the Biosimilars Industry Share on FacebookTwitterShare on LinkedinE-mail article
Pharmaceutical Processing
Biosimilars continue to gain momentum in the U.S. To date, two biosimilars have been approved in the U.S., with many more in production and going through clinical trials. “Two biosimilars have been approved, both with full extrapolation across all indications of the reference product (for which there was not existing exclusivity), demonstrating the U.S. Food and Drug Administration (FDA) is experienced and comfortable with the 351 (k) approval pathway,” said Bertrand Liang, M.D., Ph.D., M.B.A., Founding Chief Executive Officer (CEO) of Pfenex and Chair of the Generic Pharmaceutical Association Biosimilars Council.  READ MORE

Pharma Loses One Battle Over Drug Take-Back Programs, But Wins Another Share on FacebookTwitterShare on LinkedinE-mail article
The latest skirmishes over drug take-back programs yielded a mixed outcome this week for the pharmaceutical industry, which has been battling local governments that want drug makers to pick up the tab. Recently, officials in Snohomish County, Washington, voted unanimously to require drug companies to run a program that would allow consumers to dispose of unwanted and unused medicines.  READ MORE

FDA Finalizes Compounding Guidance Share on FacebookTwitterShare on LinkedinE-mail article
The FDA recently published three final guidance documents regarding the compounding of drug products. The guidance documents address the regulation of firms that compound drugs and the compounding of bulk drug substances by FDA-registered outsourcing facilities.  READ MORE

US Specialty Pharma Firms To Change Their M&A Strategies: Moody's Share on FacebookTwitterShare on LinkedinE-mail article
Business Standard
U.S. specialty pharmaceutical industry is expected to witness the start of merger and acquisitions activity as companies look to augment their portfolio with products targeted at unmet medical needs. "Despite the ongoing challenges weighing on the U.S. specialty pharmaceutical sector, companies will steadily resume M&A with a more refined focus,” said Moody’s Investors Service.  READ MORE

4 Essential Career Advice Tips For Millennials Share on FacebookTwitterShare on LinkedinE-mail article
The Huffington Post
The world that your parents grew up in is no more. Gone are the days of graduating from college and working one job for 40 years until you can collect your pension. Things don’t work like that anymore. In 2016, the modern job world is fast-paced and rapidly changing. Potential employers care more about efficiency and skill than the years of experience under your belt.  READ MORE

Drug Industry CEOs Lead New Task Force On Brexit's Pharma Fallout Share on FacebookTwitterShare on LinkedinE-mail article
Drug industry and government officials have set up a task force to address regulatory and other problems facing the pharmaceutical sector following Britain's decision to leave the European Union. Drugmakers, which overwhelmingly favored remaining in the E.U., account for 25 percent of all U.K. business research spending and companies have warned that Brexit threatens uncertainty, added complexity and potential drug approval delays.  READ MORE

Brexit Will Be Bad For Pharma Share on FacebookTwitterShare on LinkedinE-mail article
In medicine they talk about triage in making quick decisions to save lives. Central bankers and politicians across Europe will be performing financial triage this weekend on the U.K. and E.U. But Big Pharma execs and their financial staffs will also be working overtime to monitor their cash reserves and scrutinize their corporate financial structures. Blame it on Brexit.  READ MORE

How to Get Your Medical Sales Resume Found — Advice from a Medical Sales Recruiter Share on FacebookTwitterShare on LinkedinE-mail article
The number of American online job seekers has doubled since 2005, per Pew Research, and this number is expected to continue to grow. Access to jobs through online sources are greater than ever, but how do you get your resume found amongst the internet crowd? As recruiters we see hundreds of resumes a week and we have 5 must do tips to make your resume stand out.  READ MORE

FDA Clears Oral Cannabis Drug For AIDS, Cancer Patients Share on FacebookTwitterShare on LinkedinE-mail article
Medscape (free login required)
The U.S. Food and Drug Administration has approved dronabinol oral solution (Syndros, Insys Therapeutics, Inc.) for the treatment of anorexia associated with weight loss in patients with AIDS and for nausea and vomiting associated with cancer chemotherapy in patients who fail to respond adequately to conventional antiemetic treatments, according to a company news release.  READ MORE

Your Community Holds the Key To Career Success Share on FacebookTwitterShare on LinkedinE-mail article
You’ve landed your dream job. You volunteer for assignments, sign up for committees, join colleagues for happy hour. You’ve got that networking thing nailed. Right? Wrong! Yes, it’s important to build a network within your organization, getting to know — and be known by — people across departments, disciplines, levels. But it’s just as important to get involved outside your organization.  READ MORE

A Proposal To Spur Pharma R&D Investment Into Antibiotics For 'Superbugs' Share on FacebookTwitterShare on LinkedinE-mail article
Concern continues to grow over the emergence of bacteria resistant to current antibiotics. Things are getting so alarming that political leaders such as President Barack Obama, German Chancellor Angela Merkel and outgoing U.K. Prime Minister David Cameron have made antibiotic resistance a top healthcare priority in their respective countries. Despite this crisis, many major pharmaceutical companies — the very organizations best poised to help solve this challenge — remain on the sidelines.  READ MORE

AAPS Career Services
Colby Horton, Vice President of Publishing, MultiBriefs, 469.420.2601
Download media kit

Jessica Taylor, Medical Editor, MultiBriefs, 202.684.7169  
Contribute news

Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.

This edition of the AAPS Pharmaceutical Career News was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!

Recent issues

June 10, 2016
May 13, 2016
April 15, 2016
March 11, 2016

7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063